Evidence-based, research-use-only guides — reconstitution technique, verifying purity and COAs, the GLP-1 peptide family, and sourcing research peptides in Australia.
A research-focused walkthrough of peptide reconstitution: choosing bacteriostatic water volume, calculating concentration, reading syringe units and storing material correctly.
Read guide →A neutral, research-focused overview of the GLP-1/incretin peptide class and how semaglutide, tirzepatide, retatrutide and cagrilintide differ in receptor targets and the published clinical context that has driven scientific interest.
Read guide →A research-focused overview of BPC-157, the gastric-derived pentadecapeptide, covering its studied mechanisms, the preclinical evidence base, and its limitations.
Read guide →A research-focused explainer on what bacteriostatic water is, how it differs from sterile water, and why it is the standard diluent for reconstituting lyophilised research peptides.
Read guide →A rigorous, evidence-based guide to reading HPLC purity figures, Certificates of Analysis, and independent lab reports so researchers can properly vet peptide suppliers.
Read guide →A factual, educational guide to research peptides in Australia — the research-use-only framework, how to judge purity and traceability, and why local AU supply matters.
Read guide →BPC-157 and TB-500 are two of the most-studied recovery peptides in preclinical literature. This research-focused comparison examines their origins, distinct mechanisms of action, the strength and limits of the evidence, and why laboratories often study them side by side.
Read guide →The core difference between CJC-1295 with DAC and without DAC (Mod GRF 1-29) is duration: the DAC form binds albumin for a multi-day half-life, while the no-DAC form is short-acting and pulsatile. This educational guide compares the GHRH-analogue class for research contexts only.
Read guide →Semax and Selank are two Russian-developed research heptapeptides often studied side by side. This educational comparison looks at their peptide origins, the mechanisms explored in preclinical work, and the limits of the current evidence.
Read guide →A receptor-level comparison of semaglutide, tirzepatide and retatrutide — single versus dual versus triple agonism, what each receptor does mechanistically, molecular size, and why assay figures carry more weight for large lipidated peptides.
Read guide →Storage guidance written for temperate laboratories assumes material arrives as it left. In Australian summer transit it often does not — what heat, humidity and freeze-thaw do to peptides, and what a temperature excursion obliges you to do.
Read guide →Purity is a ratio with one target in the numerator — a definition that breaks as soon as a vial holds two peptides. Why per-component assay is the correct analytical treatment, illustrated with two published TXLABS blend reports.
Read guide →What happens between a vial being submitted and a certificate being published: chain of custody, reversed-phase HPLC for purity, mass spectrometry for identity, and what a report ID and verification key are actually for.
Read guide →GHK is a free tripeptide; GHK-Cu is a defined copper(II) coordination complex; AHK-Cu is the copper complex of a single-residue variant. What separates them chemically, analytically and in the depth of the published literature.
Read guide →Purity is the proportion of a sample that is the target peptide; assay is the mass actually measured against the label. They are independent numbers, and a certificate showing only one has told you half the story.
Read guide →A supplier-agnostic checklist for the Australian market: named laboratory, batch number and test date, analyte variant match, per-component assay on blends, verifiable report IDs, AUD pricing, domestic dispatch, and confirming your own regulatory position.
Read guide →MOTS-c is encoded in mitochondrial DNA. SS-31 is a synthetic tetrapeptide that binds cardiolipin. They share a destination, not an origin — and their evidence bases are entirely separate.
Read guide →Both bind the GHRH receptor and raise IGF-1. One has an approved indication and published phase 3 data; the other has small early-phase studies. What that gap teaches about reading claims.
Read guide →Invented at Monash University to separate growth hormone's fat metabolism from its other effects. It succeeded pharmacologically and failed clinically — which makes it unusually instructive.
Read guide →Loss-of-function mutations in its receptor prevent puberty starting at all. That finding identified kisspeptin as the upstream switch of the reproductive axis.
Read guide →Everything a newcomer needs in order: what turns up in the vial, the full equipment list including what not to buy, choosing a diluent, the first reconstitution step by step, and the one calculation that matters.
Read guide →